InvestorsHub Logo
Followers 276
Posts 36077
Boards Moderated 2
Alias Born 04/05/2012

Re: None

Monday, 08/19/2019 10:37:29 AM

Monday, August 19, 2019 10:37:29 AM

Post# of 1716
New data presentation on phase 2 coming

Quote

“ new clinical data from its Phase 2 trial of onvansertib, in combination with Zytiga® (abiraterone acetate)/prednisone, in metastatic Castration-Resistant Prostate Cancer (mCRPC), will be presented as an oral poster at the 20th Asia-Pacific Prostate Cancer Conference, which will be held August 23-26 in Melbourne, Australia. “

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News